Company Filing History:
Years Active: 2015
Title: Myung Hee Son: Innovator in Medicinal Chemistry
Introduction
Myung Hee Son is a notable inventor based in Namyangju-si, South Korea. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific neurological disorders. Her work is characterized by a focus on innovative solutions for complex health issues.
Latest Patents
Myung Hee Son holds 1 patent for her invention titled "2-(substituted ethynyl)quinoline derivatives as mGluR5 antagonists." This patent describes a 2-(substituted ethynyl)quinoline derivative that exhibits mGluR5 antagonistic activity, along with its pharmaceutically acceptable salts. The compound has potential applications as a medicament for treating and preventing various mGluR5 receptor-mediated diseases, including Alzheimer's disease, Parkinson's disease, and schizophrenia, among others.
Career Highlights
Myung Hee Son is affiliated with the Korea Institute of Science and Technology, where she conducts her research and development activities. Her work has been instrumental in advancing the understanding of mGluR5 receptor functions and their implications in various neurological conditions.
Collaborations
Myung Hee Son collaborates with esteemed colleagues, including Sun Joon Min and Yong Seo Cho, to further her research initiatives. These collaborations enhance the scope and impact of her work in the field of medicinal chemistry.
Conclusion
Myung Hee Son's innovative contributions to medicinal chemistry, particularly through her patent on mGluR5 antagonists, highlight her role as a key figure in addressing significant health challenges. Her ongoing research continues to pave the way for potential therapeutic advancements.